title: Alemtuzumab induction in lung transplantation: time to move on?
abstract: This editorial puts into perspective the findings of the first randomized, controlled trial examining alemtuzumab induction for lung transplantation, and highlights the challenges encountered with alemtuzumab induction in other solid organs. See article by Jaksch et al on page 1839.
authors.affiliation: Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, NC; Duke Clinical Research Institute, Durham, NC.
authors.forename: J L
authors.initials: JL
authors.lastname: Todd
authors.forename: S M
authors.initials: SM
authors.lastname: Palmer
mesh_terms: D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016040:Lung Transplantation; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000074323:Alemtuzumab